rs5937843

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_006517.5(SLC16A2):​c.1399+43T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.576 in 110,541 control chromosomes in the GnomAD database, including 16,119 homozygotes. There are 18,552 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.58 ( 16119 hom., 18552 hem., cov: 22)
Exomes 𝑓: 0.75 ( 199128 hom. 204718 hem. )
Failed GnomAD Quality Control

Consequence

SLC16A2
NM_006517.5 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.0840

Publications

12 publications found
Variant links:
Genes affected
SLC16A2 (HGNC:10923): (solute carrier family 16 member 2) This gene encodes an integral membrane protein that functions as a transporter of thyroid hormone. The encoded protein facilitates the cellular importation of thyroxine (T4), triiodothyronine (T3), reverse triiodothyronine (rT3) and diidothyronine (T2). This gene is expressed in many tissues and likely plays an important role in the development of the central nervous system. Loss of function mutations in this gene are associated with psychomotor retardation in males while females exhibit no neurological defects and more moderate thyroid-deficient phenotypes. This gene is subject to X-chromosome inactivation. Mutations in this gene are the cause of Allan-Herndon-Dudley syndrome. [provided by RefSeq, Mar 2012]
SLC16A2 Gene-Disease associations (from GenCC):
  • Allan-Herndon-Dudley syndrome
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, ClinGen, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant X-74529484-T-G is Benign according to our data. Variant chrX-74529484-T-G is described in ClinVar as Benign. ClinVar VariationId is 159903.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.798 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC16A2NM_006517.5 linkc.1399+43T>G intron_variant Intron 5 of 5 ENST00000587091.6 NP_006508.2 P36021

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC16A2ENST00000587091.6 linkc.1399+43T>G intron_variant Intron 5 of 5 1 NM_006517.5 ENSP00000465734.1 P36021
SLC16A2ENST00000590447.1 linkc.610-1849T>G intron_variant Intron 3 of 3 5 ENSP00000466213.1 K7ELT4
SLC16A2ENST00000636771.1 linkn.*1100+43T>G intron_variant Intron 6 of 6 5 ENSP00000490445.1 A0A1B0GVB4

Frequencies

GnomAD3 genomes
AF:
0.576
AC:
63643
AN:
110491
Hom.:
16133
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.211
Gnomad AMI
AF:
0.873
Gnomad AMR
AF:
0.515
Gnomad ASJ
AF:
0.779
Gnomad EAS
AF:
0.0334
Gnomad SAS
AF:
0.448
Gnomad FIN
AF:
0.776
Gnomad MID
AF:
0.720
Gnomad NFE
AF:
0.804
Gnomad OTH
AF:
0.610
GnomAD2 exomes
AF:
0.606
AC:
63477
AN:
104815
AF XY:
0.616
show subpopulations
Gnomad AFR exome
AF:
0.208
Gnomad AMR exome
AF:
0.475
Gnomad ASJ exome
AF:
0.783
Gnomad EAS exome
AF:
0.0318
Gnomad FIN exome
AF:
0.777
Gnomad NFE exome
AF:
0.810
Gnomad OTH exome
AF:
0.687
GnomAD4 exome
Data not reliable, filtered out with message: InbreedingCoeff
AF:
0.754
AC:
705707
AN:
935708
Hom.:
199128
Cov.:
16
AF XY:
0.760
AC XY:
204718
AN XY:
269428
show subpopulations
African (AFR)
AF:
0.212
AC:
4658
AN:
21951
American (AMR)
AF:
0.478
AC:
13032
AN:
27249
Ashkenazi Jewish (ASJ)
AF:
0.781
AC:
13860
AN:
17755
East Asian (EAS)
AF:
0.0208
AC:
548
AN:
26388
South Asian (SAS)
AF:
0.503
AC:
23412
AN:
46517
European-Finnish (FIN)
AF:
0.775
AC:
26028
AN:
33598
Middle Eastern (MID)
AF:
0.770
AC:
2201
AN:
2857
European-Non Finnish (NFE)
AF:
0.826
AC:
593737
AN:
718952
Other (OTH)
AF:
0.698
AC:
28231
AN:
40441
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
5541
11083
16624
22166
27707
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
15424
30848
46272
61696
77120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.576
AC:
63643
AN:
110541
Hom.:
16119
Cov.:
22
AF XY:
0.565
AC XY:
18552
AN XY:
32807
show subpopulations
African (AFR)
AF:
0.211
AC:
6452
AN:
30515
American (AMR)
AF:
0.514
AC:
5342
AN:
10385
Ashkenazi Jewish (ASJ)
AF:
0.779
AC:
2040
AN:
2618
East Asian (EAS)
AF:
0.0332
AC:
117
AN:
3521
South Asian (SAS)
AF:
0.449
AC:
1181
AN:
2630
European-Finnish (FIN)
AF:
0.776
AC:
4471
AN:
5764
Middle Eastern (MID)
AF:
0.721
AC:
155
AN:
215
European-Non Finnish (NFE)
AF:
0.804
AC:
42393
AN:
52716
Other (OTH)
AF:
0.601
AC:
901
AN:
1500
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
678
1356
2035
2713
3391
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
552
1104
1656
2208
2760
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.711
Hom.:
70921
Bravo
AF:
0.541

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jun 26, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Allan-Herndon-Dudley syndrome Benign:1
Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
0.58
DANN
Benign
0.55
PhyloP100
0.084
Mutation Taster
=5/95
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs5937843; hg19: chrX-73749319; COSMIC: COSV52084469; API